An international clinical trial testing the effectiveness of the drug remdesivir on patients hospitalised with COVID-19, has shown “very promising” preliminary results. These results were published last week in the New England Journal of Medicine. Launched at the end of March, the Adaptive COVID -19 Treatment Trial (ACTT-EU/UK) trial, is taking place in about 75 hospitals glob ...
Here you can find all the latest news from the MRC CTU at UCL.
Di Gibb elected a Fellow of the Academy of Medical Sciences
ACTT-EU/UK trial finds remdesivir speeds up COVID-19 recovery
Tribute to Lynda Harper
Tribute to Gita Ramjee and Emmanuel Harding